1 / 4

Contraceptive Drugs and Devices Market Analysis, Market Size, Share, Regional Outlook, Industry Trends, Competitive Stra

Contraceptive drugs and devices market is expected to grow over the forecast period owing to the increasing prevalence of sexually transmitted diseases such as HIV & HPV and growing population.

hexaresrch
Download Presentation

Contraceptive Drugs and Devices Market Analysis, Market Size, Share, Regional Outlook, Industry Trends, Competitive Stra

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Hexa Research Inc. Industry Research,Custom Research & Consulting Contraceptive Drugs and Devices Market Analysis, Market Size, Share, Regional Outlook, Industry Trends, Competitive Strategies And Segment Forecasts, 2012 To 2020 Industry Insights Contraceptive drugs and devices market is expected to grow over the forecast period owing to the increasing prevalence of sexually transmitted diseases such as HIV & HPV and growing population. The other drivers of this market are increasing government & NGO’s programs against the abortion, social & political consideration, and changing lifestyle. Contraceptive drugs & devices are the commonly known for birth and fertility control and are used to avoid pregnancy. Function of these devices & drugs is to change ovulation mechanism by acting as a physical barrier between ovum and sperm. Lack of contraception results have impacted on healthcare costs due to the unwanted abortions and pregnancies. The usage, planning and provisions of contraceptives are known as family planning. There are various advantages attached to the contraceptive drugs & devices as it helps in the prevention of spread of sexually transmitted diseases. Browse Detail Report With TOC @ http://www.hexaresearch.com/research-report/contraceptive- drugs-and-devices-industry/

  2. Hexa Research Inc. Industry Research,Custom Research & Consulting Family planning includes application of intra-uterine devices, sterilization, hormonal barrier as a method for birth control. Apart from these, there are emergency controls, dual protection and behavioral are available for prevention of pregnancy. Global market for contraceptives encompasses female contraceptive devices, male contraceptive devices, and vaginal, oral, and injectable contraceptive drugs. These contraceptive devices and drugs are available globally in almost all the outlets ranging from chemists, pharmacies, fertility centers and reproductive health centers. All the sexually active females at childbearing age are at a risk of unwanted pregnancies due to unsafe sex. There has been tremendous growth in the sexually transmitted diseases sector and the global population, due to the lack of awareness about the contraceptive drugs and devices. All these have generated awareness among the people to curb unplanned and unwanted pregnancies. This market has a huge unmet opportunity over the forecast period. Product Insights Contraceptive drugs and devices market is segmented on the basis of product types into contraceptive drugs, female contraceptive devices, and male contraceptive devices. Among these, largest share is held by contraceptive drugs as of 2014, as it is easiest method of contraception. There has been lot of technological advancements in contraceptive drugs such as as development of emergency oral contraceptive pills. These contraceptive drugs are used for preventing unwanted pregnancy. These drugs are composition of one or more synthetic female sex hormones like progestin or progestin and estrogen. So it prevents pregnancy by blocking the normal and complex process of ovulation. It helps by prohibiting implantation of male hormones within the uterus, if it is taken within 2-3 days. Simplicity of their usage makes it prominent contraceptive in the market. The other forms of contraceptive drugs are injectable and topical, had also witnessed strong growth rate. Request A Sample copy of This Report @ http://www.hexaresearch.com/sample/177 Moreover, the contraceptive drugs and devices market has witnessed growth due to the introduction of cheap contraceptives such as Pill-Plus, AG200-15 Contraceptive Patch and Sino-Implant (II). Female contraceptive devices are the fastest growing market. This market is further classified into, sub-dermal contraceptive implants, female condoms, contraceptive vaginal rings, intrauterine devices, contraceptive sponges, contraceptive diaphragm and non-surgical permanent contraception device. Regional Insights Geographically, the Contraceptive drugs and devices market is studied with respect to four regions such as North America, Europe, Asia Pacific and RoW. Among these, North America and Europe is dominating

  3. Hexa Research Inc. Industry Research,Custom Research & Consulting the whole market owing to its sophisticated healthcare infrastructure, increasing awareness, availability of contraceptive drugs & devices, technologically advanced systems, and government initiatives. Over the forecast period, most of the domestic and international players are focusing on the emerging market, such as China, India, as these markets are lucrative by nature, and owe towards untapped opportunity, and these countries are growing rapidly in the contraceptive drugs and devices market. Competitive Insights The major players in the, Contraceptive drugs and devices market are Merck & Co., Bayer Healthcare AG, Warmer Chilcott Company inc., Church & Dwight Co. Inc., Pfizer Inc., Agile Therapeutics Inc., Mayer Laboratories Inc., BioSante Pharmaceuticals, Teva Pharmaceutical Industries Ltd, and Pantarhei Bioscience B.V. Table of Contents Chapter 1. Executive Summary 1.1. Contraceptive - Industry Summary & Critical Success Factors (CSFs) Chapter 2. Contraceptive Industry Outlook 2.1. Market Segmentation 2.2. Market Size and Growth Prospects 2.3. Contraceptive Market Dynamics 2.4. Key Opportunities Prioritized 2.5. Industry Analysis - Porter's 2.6. Contraceptive - Company Market Share Analysis, 2013 2.7. Contraceptive market PESTEL Analysis, 2013 Browse All Pharmaceuticals Industry Research Related Reports @ http://www.hexaresearch.com/research-category/pharmaceuticals-industry/ Chapter 3. Contraceptive Product Outlook 3.1. Contraceptive Drugs 3.2. Male Contraceptive Devices (Condoms) 3.3. Female Contraceptive Devices Chapter 4. Contraceptive Regional Outlook 4.1. North America

  4. Hexa Research Inc. Industry Research,Custom Research & Consulting 4.2. Europe 4.3. Asia Pacific 4.4. RoW Chapter 5 Competitive Landscape 5.1 Agile Therapeutics Inc. 5.2 Bayer Healthcare AG 5.3 BioSante Pharmaceuticals Inc. 5.4 Church & Dwight Co. Inc. 5.5 Mayer Laboratories Inc. 5.6 Merck & Co. Chapter 6. Methodology and Scope 6.1. Research Methodology 6.2. Research Scope & Assumption 6.3. List of Data Sources Browse Full Report @ http://www.hexaresearch.com/research-report/contraceptive-drugs-and- devices-industry/ About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Information: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - http://www.hexaresearch.com/ Visit our Blogs: http://hexaresearchinc.blogspot.com/

More Related